Ailiang Zeng

2.8k total citations · 1 hit paper
42 papers, 2.0k citations indexed

About

Ailiang Zeng is a scholar working on Molecular Biology, Cancer Research and Surgery. According to data from OpenAlex, Ailiang Zeng has authored 42 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 33 papers in Molecular Biology, 27 papers in Cancer Research and 4 papers in Surgery. Recurrent topics in Ailiang Zeng's work include MicroRNA in disease regulation (20 papers), Circular RNAs in diseases (18 papers) and Cancer-related molecular mechanisms research (15 papers). Ailiang Zeng is often cited by papers focused on MicroRNA in disease regulation (20 papers), Circular RNAs in diseases (18 papers) and Cancer-related molecular mechanisms research (15 papers). Ailiang Zeng collaborates with scholars based in China, United States and Türkiye. Ailiang Zeng's co-authors include Yongping You, Jianxing Yin, Zhuoran Zhang, Wei Yan, Chenfei Lu, Yutian Wei, Xiaoxu Huang, Zhumei Shi, Xu Zhou and Qi Hu and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Oncogene.

In The Last Decade

Ailiang Zeng

40 papers receiving 2.0k citations

Hit Papers

Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin... 2019 2026 2021 2023 2019 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ailiang Zeng China 24 1.7k 1.5k 204 123 102 42 2.0k
Xiefeng Wang China 23 1.4k 0.8× 1.2k 0.8× 208 1.0× 155 1.3× 102 1.0× 45 1.8k
Simona Cazacu United States 22 1.4k 0.8× 719 0.5× 245 1.2× 212 1.7× 65 0.6× 32 1.8k
Valeria Coppola Italy 15 1.4k 0.8× 1.3k 0.9× 175 0.9× 138 1.1× 195 1.9× 25 1.8k
Chuan Fang China 23 854 0.5× 643 0.4× 266 1.3× 159 1.3× 133 1.3× 43 1.3k
Hongquan Yu China 16 732 0.4× 454 0.3× 138 0.7× 168 1.4× 77 0.8× 36 1.0k
Aidong Zhou China 20 2.2k 1.3× 1.1k 0.8× 127 0.6× 346 2.8× 125 1.2× 44 2.6k
Junjie Gu China 22 1.1k 0.6× 345 0.2× 142 0.7× 161 1.3× 67 0.7× 53 1.4k
Silvia Martı́n-Puig Spain 16 1.8k 1.1× 424 0.3× 146 0.7× 68 0.6× 148 1.5× 22 2.3k
Xiaobai Liu China 25 1.2k 0.7× 1.1k 0.7× 146 0.7× 107 0.9× 84 0.8× 46 1.6k

Countries citing papers authored by Ailiang Zeng

Since Specialization
Citations

This map shows the geographic impact of Ailiang Zeng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ailiang Zeng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ailiang Zeng more than expected).

Fields of papers citing papers by Ailiang Zeng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ailiang Zeng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ailiang Zeng. The network helps show where Ailiang Zeng may publish in the future.

Co-authorship network of co-authors of Ailiang Zeng

This figure shows the co-authorship network connecting the top 25 collaborators of Ailiang Zeng. A scholar is included among the top collaborators of Ailiang Zeng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ailiang Zeng. Ailiang Zeng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Song, Chengwei Wu, Jiawei Wang, et al.. (2025). Hsa_circ_0002301 inhibits ferroptosis in gastric cancer by encoding the de novo protein HECTD1-463aa. Journal of Translational Medicine. 23(1). 250–250. 2 indexed citations
3.
Zeng, Haojie, et al.. (2025). MiRNA-loaded MSC exosomes restore autophagy flux for acute pancreatitis therapy. Frontiers in Immunology. 16. 1613716–1613716.
4.
Yin, Jianxing, Xin Ge, Ailiang Zeng, et al.. (2023). METTL3-mediated m6A modification of LINC00839 maintains glioma stem cells and radiation resistance by activating Wnt/β-catenin signaling. Cell Death and Disease. 14(7). 417–417. 37 indexed citations
5.
Zhang, Shaolin, Shun Yao, Jinping Chen, et al.. (2023). Correlation between tumor invasion and somatostatin receptor subtypes in acromegaly. Journal of neurosurgery. 140(4). 1019–1028. 5 indexed citations
7.
Bouchmaa, Najat, et al.. (2022). Metabolic Rewiring in Glioblastoma Cancer: EGFR, IDH and Beyond. Frontiers in Oncology. 12. 901951–901951. 41 indexed citations
8.
Shin, Seula, Hao Zhou, Chenxi He, et al.. (2021). Qki activates Srebp2-mediated cholesterol biosynthesis for maintenance of eye lens transparency. Nature Communications. 12(1). 3005–3005. 30 indexed citations
9.
Zhang, Qiang, Hao Hu, Hao Chen, et al.. (2020). CircRNACCDC66 regulates cisplatin resistance in gastric cancer via the miR-618/BCL2 axis. Biochemical and Biophysical Research Communications. 526(3). 713–720. 44 indexed citations
10.
Tao, Tao, et al.. (2020). Establishing a novel prediction model for improving the positive rate of prostate biopsy. Translational Andrology and Urology. 9(2). 574–582. 6 indexed citations
11.
Yao, Shun, Pan Lin, Farhana Akter, et al.. (2020). Hormone levels are related to functional compensation in prolactinomas: A resting-state fMRI study. Journal of the Neurological Sciences. 411. 116720–116720. 8 indexed citations
12.
Zeng, Ailiang, Zhiyun Wei, Rosalia Rabinovsky, et al.. (2020). Glioblastoma-Derived Extracellular Vesicles Facilitate Transformation of Astrocytes via Reprogramming Oncogenic Metabolism. iScience. 23(8). 101420–101420. 47 indexed citations
13.
Z, Liu, et al.. (2019). MicroRNA-3662 targets ZEB1 and attenuates the invasion of the highly aggressive melanoma cell line A375. SHILAP Revista de lepidopterología. 2 indexed citations
14.
Yin, Jianxing, Ailiang Zeng, Zhuoran Zhang, et al.. (2019). Exosomal transfer of miR-1238 contributes to temozolomide-resistance in glioblastoma. EBioMedicine. 42. 238–251. 152 indexed citations
15.
Huang, Xiaoxu, Zheng Li, Qiang Zhang, et al.. (2019). Circular RNA AKT3 upregulates PIK3R1 to enhance cisplatin resistance in gastric cancer via miR-198 suppression. Molecular Cancer. 18(1). 71–71. 323 indexed citations breakdown →
16.
Tu, Yiming, Peng Xie, Liang Fan, et al.. (2019). S100A11 functions as novel oncogene in glioblastoma via S100A11/ANXA2/NF‐κB positive feedback loop. Journal of Cellular and Molecular Medicine. 23(10). 6907–6918. 39 indexed citations
17.
Zeng, Ailiang, Zhiyun Wei, Wei Yan, et al.. (2018). Exosomal transfer of miR-151a enhances chemosensitivity to temozolomide in drug-resistant glioblastoma. Cancer Letters. 436. 10–21. 161 indexed citations
18.
Nie, Er, Xin Jin, Weining Wu, et al.. (2018). Fstl1/DIP2A/MGMT signaling pathway plays important roles in temozolomide resistance in glioblastoma. Oncogene. 38(15). 2706–2721. 37 indexed citations
19.
Zeng, Ailiang, Wei Yan, Zheng Wang, et al.. (2017). Tumour exosomes from cells harbouring PTPRZ1–MET fusion contribute to a malignant phenotype and temozolomide chemoresistance in glioblastoma. Oncogene. 36(38). 5369–5381. 100 indexed citations
20.
Jin, Xin, Er Nie, Xu Zhou, et al.. (2017). Fstl1 Promotes Glioma Growth Through the BMP4/Smad1/5/8 Signaling Pathway. Cellular Physiology and Biochemistry. 44(4). 1616–1628. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026